De Sarro G B, De Sarro A
Institute of Pharmacology, University of Reggio Calabria, Italy.
Neuropharmacology. 1989 Mar;28(3):211-5. doi: 10.1016/0028-3908(89)90095-6.
The anticonvulsant activity of 5-chloro-4-(2-imidazolin-2yl-amino)-2,1,3-benzothiazole, tizanidine, was studied following intraperitoneal (i.p.) administration in DBA/2 mice (which show sound-induced seizures). Protection against sound-induced seizures was observed after tizanidine, (0.5-4 mg/kg i.p.). The ED50 values for suppression of the tonic, clonic and wild running phases of sound-induced seizures were 0.54, 0.76 and 1.43 mg/kg, respectively. This protective action was significantly reduced by pretreatment with aminophylline (25 mg/kg i.p.), yohimbine (1 mg/kg i.p.) or piperoxan (20 mg/kg i.p.). Methysergide, a serotonin antagonists, did not significantly reduce the anticonvulsant effects of tizanidine. The present experiments suggest an involvement of purinergic and adrenergic mechanisms in the anticonvulsant action of tizanidine.
研究了5-氯-4-(2-咪唑啉-2-基氨基)-2,1,3-苯并噻唑(替扎尼定)在DBA/2小鼠(表现出声音诱发惊厥)腹腔注射后的抗惊厥活性。腹腔注射替扎尼定(0.5 - 4毫克/千克)后,观察到对声音诱发惊厥的保护作用。抑制声音诱发惊厥的强直、阵挛和狂奔阶段的半数有效量(ED50)值分别为0.54、0.76和1.43毫克/千克。用氨茶碱(25毫克/千克腹腔注射)、育亨宾(1毫克/千克腹腔注射)或哌罗克生(20毫克/千克腹腔注射)预处理可显著降低这种保护作用。5-羟色胺拮抗剂麦角新碱并未显著降低替扎尼定的抗惊厥作用。本实验表明嘌呤能和肾上腺素能机制参与了替扎尼定的抗惊厥作用。